Burning Rock Biotech Ltd ADR (BNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -92,070 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 18,789 | N/A |
| Accounts receivable | N/A | N/A | N/A | -1,745 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -4,384 | N/A |
| Other Working Capital | N/A | N/A | N/A | -7,347 | N/A |
| Other Operating Activity | -15,863 | -11,152 | -5,569 | 50,731 | -32,862 |
| Operating Cash Flow | $-15,863 | $-11,152 | $-5,569 | $-36,026 | $-32,862 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1,129 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -180 | N/A |
| Other Investing Activity | -513 | -360 | -330 | -180 | -1,230 |
| Investing Cash Flow | $-513 | $-360 | $-330 | $-1,309 | $-1,230 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | N/A | N/A | -983 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -5,895 | -6,431 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-6,878 | $-6,431 |
| Exchange Rate Effect | -292 | 204 | 7 | 543 | 978 |
| Beginning Cash Position | 87,668 | 84,657 | 85,206 | 130,321 | 126,819 |
| End Cash Position | 71,000 | 73,349 | 79,314 | 86,651 | 87,274 |
| Net Cash Flow | $-16,668 | $-11,308 | $-5,892 | $-43,670 | $-39,545 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,863 | -11,152 | -5,569 | -36,026 | -32,862 |
| Capital Expenditure | N/A | N/A | N/A | -1,141 | N/A |
| Free Cash Flow | -15,863 | -11,152 | -5,569 | -37,167 | -32,862 |